Inventor · disambiguated record
Yujia Dai
Also filed as: DAI YUJIA
18 granted patents·31 pending applications·391 citations·filing 1996–2025
94Inventor score
Top patents by PatentIndex Score
49 records- 0198US7297709B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBOTT LAB·Filed 2004·Granted Nov 20, 2007·92 cites·37 claims
- 0297US6294573B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted Sep 25, 2001·131 cites·17 claims
- 0396US6235786B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted May 22, 2001·103 cites·13 claims
- 0493US8063091B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsDAI YUJIA·Filed 2009·Granted Nov 22, 2011·13 cites·21 claims
- 0589US7812166B2Kinase inhibitorsABBOTT LAB·Filed 2005·Granted Oct 12, 2010·15 cites·4 claims
- 0689US7598283B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBOTT LAB·Filed 2007·Granted Oct 6, 2009·5 cites·12 claims
- 0788US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 0887US9932340B2Substituted indolesABBVIE INC·Filed 2015·Granted Apr 3, 2018·7 cites·27 claims
- 0987US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 1080US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 1179US9957263B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted May 1, 2018·3 cites·5 claims
- 1278US10035800B2Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jul 31, 2018·3 cites·48 claims
- 1377US9321764B2Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2014·Granted Apr 26, 2016·3 cites·25 claims
- 1477US2022259226A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2022·Application pending·0 cites
- 1576US8299243B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsDAI YUJIA·Filed 2011·Granted Oct 30, 2012·1 cites·8 claims
- 1676US8110572B2Inhibitors of protein kinasesDAI YUJIA·Filed 2008·Granted Feb 7, 2012·2 cites·15 claims
- 1776US2025066388A11,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 1875US10131657B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 20, 2018·2 cites·14 claims
- 1972US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2070US2021292339A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2020·Application pending·0 cites
- 2170US2021070756A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2269US7560552B2Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jul 14, 2009·3 cites·2 claims
- 2369US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2468US2020291027A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2566US8940778B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBVIE INC·Filed 2013·Granted Jan 27, 2015·0 cites·8 claims
- 2665US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 2765US2020255451A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 2865US2019055264A1Macrocyclic MCL-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 2964US8642776B2Indazole, benzisoxazole, and benzisothiazole kinase inhibitorsABBVIE INC·Filed 2012·Granted Feb 4, 2014·0 cites·4 claims
- 3064US2020010480A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2019·Application pending·0 cites
- 3163US2019389861A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 3261US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 3361US2018298003A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 3458US2016143916A1Bromodomain inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3556US2019084981A1Bromodomain InhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 3654US2018193315A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2018·Application pending·0 cites
- 3753US2018071262A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2017·Application pending·0 cites
- 3851US2025333394A1Tiparp Inhibitor CompoundsABBVIE INC·Filed 2025·Application pending·0 cites
- 3951US2006276490A1Thiopyrimidine and isothiazolopyrimidine Kinase InhibitorsMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 4047US2007135387A1Inhibitors of protein kinasesMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 4147US2016235716A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2015·Application pending·0 cites
- 4244US2016237084A1Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 4343US2003225273A1Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsFiled 2003·Application pending·0 cites
- 4442US2004235892A1Indazole and benzisoxazole kinase inhibitorsFiled 2003·Application pending·0 cites
- 4539US2002177594A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 4639US2003181468A1Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsFiled 2002·Application pending·0 cites
- 4737US2002091148A13-substituted indole antiproliferative angiogenesis inhibitorsFiled 2001·Application pending·0 cites
- 4834US2018093956A1Substituted phthalazinesABBVIE INC·Filed 2015·Application pending·0 cites
- 4930US5830984ASynthesis of optically active helical ladder polymers with unbroken double-bond conjugationUNIV COLUMBIA·Filed 1996·Granted Nov 3, 1998·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Yujia Dai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →